BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1921137)

  • 1. [Use of taurine in the treatment of experimental congestive heart failure].
    Orlova TsR; Elizarova EP; Ryff IM; Fetisova NI; Mit'kina LI
    Kardiologiia; 1991 Jun; 31(6):77-80. PubMed ID: 1921137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits.
    Azuma J; Takihara K; Awata N; Ohta H; Sawamura A; Harada H; Kishimoto S
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):261-70. PubMed ID: 6484312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of taurine in rabbits with chronic congestive heart failure.
    Takihara K; Azuma J; Awata N; Ohta H; Hamaguchi T; Sawamura A; Tanaka Y; Kishimoto S; Sperelakis N
    Am Heart J; 1986 Dec; 112(6):1278-84. PubMed ID: 3788775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on heart membranes after taurine treatment in rabbits with congestive heart failure.
    Elizarova EP; Orlova TR; Medvedeva NV
    Arzneimittelforschung; 1993 Mar; 43(3):308-12. PubMed ID: 8387787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathomorphological and morphometric evaluation of a model of aortic insufficiency in rabbits treated with taurine].
    Ryff IM; Elizarova EP; Orlova TsR; Faron RA; Puchkova VA; Petrusenko AN; Rudzhianskaĭte AF
    Biull Eksp Biol Med; 1990 Jun; 109(6):600-3. PubMed ID: 2397307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical efficacy of taufon in the combined treatment of patients with chronic circulatory failure].
    Zavolovskaia LI; Elizarova EP; Orlov VA
    Eksp Klin Farmakol; 1995; 58(6):29-32. PubMed ID: 8704607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
    Azuma J; Sawamura A; Awata N; Ohta H; Hamaguchi T; Harada H; Takihara K; Hasegawa H; Yamagami T; Ishiyama T
    Clin Cardiol; 1985 May; 8(5):276-82. PubMed ID: 3888464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic strategies in the management of congestive heart failure.
    Brozena S; Jessup M
    Annu Rev Med; 1990; 41():65-74. PubMed ID: 2184749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of nitroglycerin in the treatment of congestive heart failure].
    Curyło AM
    Folia Med Cracov; 1989; 30(1-2):23-9. PubMed ID: 2518363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group.
    Azuma J
    Adv Exp Med Biol; 1994; 359():425-33. PubMed ID: 7887286
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of taurine supplementation on exercise capacity of patients with heart failure.
    Beyranvand MR; Khalafi MK; Roshan VD; Choobineh S; Parsa SA; Piranfar MA
    J Cardiol; 2011 May; 57(3):333-7. PubMed ID: 21334852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurine and failing heart: experimental and clinical aspects.
    Azuma J; Takihara K; Awata N; Sawamura A; Ohta H; Hamaguchi T; Tanaka Y; Fukuda K; Kishimoto S
    Prog Clin Biol Res; 1985; 179():195-213. PubMed ID: 4059214
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II.
    Ito T; Schaffer S; Azuma J
    Amino Acids; 2014 Jan; 46(1):111-9. PubMed ID: 23722414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine for treatment of congestive heart failure in humans.
    Azuma J; Hasegawa H; Awata N; Sawamura A; Harada H; Ogura K; Ohta H; Yamauchi K; Kishimoto S
    Prog Clin Biol Res; 1983; 125():61-72. PubMed ID: 6348797
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of congestive heart failure with orally administered taurine.
    Azuma J; Hasegawa H; Sawamura A; Awata N; Ogura K; Harada H; Yamamura Y; Kishimoto S
    Clin Ther; 1983; 5(4):398-408. PubMed ID: 6871923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The subcellular pathophysiology of heart failure due to toxic-allergic myocarditis and the action of refracterin on intracardiac hemodynamics and the functional state of the 3 subcellular cardiomyocyte systems responsible for the act of contraction-relaxation].
    Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II; Guchua EI
    Patol Fiziol Eksp Ter; 1999; (3):3-8. PubMed ID: 10498985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antagonism for different doses of taurine on calcium overload in myocardial cells of diastole heart failure rat model].
    Zhang X; Qu Y; Zhang T; Zhang Q
    Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(3):328-31. PubMed ID: 19445160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Taurine level in the blood and myocardium of rabbits with experimental heart failure].
    Orlova TsR; Iakushkin VV; Elizarova EP
    Fiziol Zh (1978); 1990; 36(6):3-7. PubMed ID: 2083583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Norepinephrine-induced heart failure and the protective effect of taurine].
    Popovich MI; Kobets VA; Kapel'ko VI
    Fiziol Zh (1978); 1990; 36(6):8-12. PubMed ID: 2083593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH; Keren G; Reis D; Sonnenblick EH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.